A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced ...
Nov 6, 2023
0
72
A new study by a team of researchers at the University of Toronto's Emerging and Pandemic Infections Consortium (EPIC) has uncovered biological reasons underlying sex differences in COVID-19 outcomes, offering a promising ...
Oct 3, 2023
0
18
A synthetic peptide developed by researchers at the Medical College of Georgia could help reduce vascular problems associated with acute respiratory distress syndrome (ARDS) in COVID-19.
Oct 3, 2023
0
23
The surface protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known as the spike protein, is critical for infecting host cells. The spike protein facilitates the infection process by binding to ...
Aug 30, 2023
0
11
In the latest research published in the Journal of Colloid and Interface Science, a large collaboration of European investigators led by Prof Marité Cárdenas of Malmö University, gained insights into how the SARS-CoV-2 ...
Jun 30, 2023
0
30
An experimental "decoy" has provided long-term protection from infection by the pandemic virus in mice, a new study finds.
May 30, 2023
0
48
An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2. In a new investigation, scientists from La Jolla Institute for Immunology (LJI) have shown how antibodies, ...
Apr 25, 2023
0
73
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, ...
Apr 13, 2023
0
87
Researchers searching for new therapeutic targets in the SARS-CoV-2 virus have identified a potential Achilles' heel that exists in all coronaviruses, according to a study published today in eLife.
Mar 21, 2023
0
136
The magnitude and quality of a key immune cell's response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people without ...
Mar 20, 2023
0
49
